Search Within

Victor Reuter

  1. "Body Imaging Service"
Formats
  1. Journal Article (19)
  2. Meeting Abstract (3)
Groups
  1. Body Imaging Service (22)
  2. Department of Pathology and Laboratory Medicine (22)
  3. Radiology, Department of (22)
  4. Department of Medicine (16)
  5. Solid Tumor Oncology Division (16)
  6. Genitourinary Oncology Service (15)

More Groups

People
  1. Oguz Akin (9)
  2. Robert Motzer (9)
  3. Hedvig Hricak (7)
  4. Paul Russo (6)
  5. Amita Dave (5)
  6. Darren Feldman (5)

More People

Years
  1. 2022 (1)
  2. 2020 (1)
  3. 2019 (1)
  4. 2018 (1)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Radiology (5)
  2. Journal of Clinical Oncology (4)
  3. Cancer (2)
  4. Clinical Cancer Research (2)
  5. Journal of Urology (2)
  6. Acta Oncologica (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (5)
  2. Radiological Society of North America, Inc. (5)
  3. American Association for Cancer Research (3)
  4. Elsevier Science, Inc. (3)
  5. Springer (2)
  6. Wiley Blackwell (2)

More Publishers

Results (22)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • DICER1-associated anaplastic sarcoma of the kidney with coexisting activating PDGFRA D842V mutations and response to targeted kinase inhibitors in one patient
    Journal Article

    Antonescu, C. R.; Reuter, V. E.; Keohan, M. L.; Hwang, S.; Chi, P.
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Everolimus plus bevacizumab is an effective first-line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial
    Journal Article

    Feldman, D. R.; Ged, Y.; Lee, C. H.; Knezevic, A.; Molina, A. M.; Chen, Y. B.; Chaim, J.; Coskey, D. T.; Murray, S.; Tickoo, S. K.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla
    Journal Article

    Mazaheri, Y.; Shukla-Dave, A.; Goldman, D. A.; Moskowitz, C. S.; Takeda, T.; Reuter, V. E.; Akin, O.; Hricak, H.
    Magnetic Resonance Imaging (2019)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II trial and correlative genomic analysis of everolimus plus bevacizumab in advanced non-clear cell renal cell carcinoma
    Journal Article

    Voss, M. H.; Molina, A. M.; Chen, Y. B.; Woo, K. M.; Chaim, J. L.; Coskey, D. T.; Redzematovic, A.; Wang, P.; Lee, W.; Selcuklu, S. D.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Tumor genetic analyses of patients with metastatic renal cell carcinoma and extended benefit from mTOR inhibitor therapy
    Journal Article

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Clinical Cancer Research (2014)

    Fulltext@MSK | Save
  • Pathway convergent evolution underscores treatment response to MTOR inhibitors in kidney cancers
    Meeting Abstract

    Voss, M. H.; Hakimi, A. A.; Pham, C. G.; Brannon, A. R.; Chen, Y. B.; Cunha, L. F.; Akin, O.; Liu, H.; Takeda, S.; Scott, S. N.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: A prospective study
    Journal Article

    Vargas, H.; Akin, O.; Shukla-Dave, A.; Zhang, J.; Zakian, K. L.; Zheng, J.; Kanao, K.; Goldman, D. A.; Moskowitz, C. S.; Reuter, V. E.; more...
    Radiology (2012)

    Fulltext@MSK | Save